Sveikiname prisijungus prie Roche Foundation Medicine interneto svetainės.

Šioje svetainėje nepateikiama medicininių patarimų ir (arba) gydymo nurodymų. Jis sukurtas Foundation Medicine partnerės bendrovės Roche, todėl išsami informacija pateikiama anglų kalba.

Pasirinkite tinkamą skiltį:

The Roche Foundation Medicine collaboration

Roche Foundation Medicine are collaborating to pioneer progress in precision medicine for cancer patients around the world

As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Thanks to Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation and experience in cancer profiling, together we are:1

  • Increasing understanding of tumours and providing insights on clinical trials to consider, to enable smarter, more efficient research and development
  • Improving patient care by providing genomic insights with associated targeted therapies, immunotherapies and relevant clinical trials
Molecular understanding of cancer Help patients find clinical trials Help select treatment plans Database & Analytics interface R&D Collaboration Clinical Practice Collaboration Patient outcomes
References
  1. Roche Media Release, 2018. Available at: https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed March 2019).